Effect of empagliflozin on no-reflow in patients with st elevation myocardial infarction undergoing primary percutaneous coronary intervention
Event: ESC Congress 2024
Topic: Revascularisation
Session: Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications
